MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$35,037K
EPS
-$1.81
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
31,175
19,819
16,024*
20,860
General and administrative
5,015
4,485
3,932*
3,557
Total operating expenses
36,190
24,304
19,956
24,417
Operating loss
-36,190
-24,304
-19,956*
-24,417
Interest and investment income, net
1,164
1,402
1,872*
1,125
Interest expense
-
-
0*
0
Other (expense) income, net
-11
-67
1,054*
-50
Total other income, net
1,153
1,335
2,926*
1,075
Net loss
-35,037
-22,969
-17,031
-23,342
Basic EPS
-1.81
-1.23
-1.106
-1.9
Diluted EPS
-1.81
-1.23
-1.106
-1.9
Basic Average Shares
19,407,688
18,706,622
15,403,607
12,307,298
Diluted Average Shares
19,407,688
18,706,622
15,403,607
12,307,298
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
CRBP Income Statement Sankey Diagram
Sankey diagram visualizing CRBP income statement for the period
Interest and investment
income, net
$1,164K
(-11.42%↓ Y/Y)
Net loss
-$35,037K
(-98.38%↓ Y/Y)
Total other income,
net
$1,153K
(-22.62%↓ Y/Y)
Other (expense)
income, net
-$11K
(-106.25%↓ Y/Y)
Operating loss
-$36,190K
(-88.96%↓ Y/Y)
Total operating
expenses
$36,190K
(88.96%↑ Y/Y)
Research and development
$31,175K
(105.27%↑ Y/Y)
General and
administrative
$5,015K
(26.48%↑ Y/Y)
Buy us a coffee
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)